Supreme Court extends protection for mifepristone access.

The Supreme Court has extended nationwide access to mifepristone, a key drug used by millions of women to terminate early pregnancies, until the end of Friday. The court is considering a decision by the U.S. Court of Appeals for the 5th Circuit that rolled back the FDA’s actions since 2016 liberalizing access to mifepristone. The Biden administration, abortion providers, and anti-abortion activists, drugmakers, and the FDA have engaged in a rapid and at times confusing legal battle over mifepristone, which is used in more than half of the nation’s abortion procedures.